VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q48516853 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241120235919.0
008 241120nneanz||abbn n and d
035 ‎‡a (WKP)Q48516853‏
024 ‎‡a 0000-0002-3997-1328‏ ‎‡2 orcid‏
024 ‎‡a 7101923208‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q48516853‏
046 ‎‡s 19000000‏
100 0 ‎‡a Renata Rizzo‏ ‎‡c researcher‏ ‎‡9 en‏
375 ‎‡a 2‏ ‎‡2 iso5218‏
400 0 ‎‡a Renata Rizzo‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's ADHD and Epilepsy in children with Tourette Syndrome: a triple comorbidity?‏
670 ‎‡a Author's Aggressive behavior in patients with Sotos syndrome.‏
670 ‎‡a Author's Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection‏
670 ‎‡a Author's Association between D18S474 locus on chromosome 18q12 and idiopathic generalized epilepsy‏
670 ‎‡a Author's Association of adenosine deaminase polymorphism with mild mental retardation.‏
670 ‎‡a Author's Association of Trp53 polymorphic variants at codon 72 with nonsyndromic mental retardation.‏
670 ‎‡a Author's Autoimmune neuropsychiatric disorders associated with streptococcal infection: Sydenham chorea, PANDAS, and PANDAS variants‏
670 ‎‡a Author's Autosomal dominant and sporadic radio-ulnar synostosis.‏
670 ‎‡a Author's Autosomal-recessive microcephaly in two siblings, one with normal IQ and both with protruding mandible, small ears, and curved nose.‏
670 ‎‡a Author's Blink reflex abnormalities in children with Tourette syndrome‏
670 ‎‡a Author's Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome‏
670 ‎‡a Author's Circulating miRNAs profiles in Tourette syndrome: molecular data and clinical implications.‏
670 ‎‡a Author's Clinical correlates of quality of life in Tourette syndrome‏
670 ‎‡a Author's Clinical manifestations and evaluation of isolated lissencephaly‏
670 ‎‡a Author's Clinical pharmacology of comorbid attention deficit hyperactivity disorder in Tourette syndrome‏
670 ‎‡a Author's Convulsive disorder and genetic polymorphism. Association of idiopathic generalized epilepsy with haptoglobin polymorphism‏
670 ‎‡a Author's Craniofacial anomalies, severe cerebellar hypoplasia, psychomotor and growth delay in a child with congenital hypothyroidism‏
670 ‎‡a Author's CSF N-glycan profile reveals sialylation deficiency in a patient with GM2 gangliosidosis presenting as childhood disintegrative disorder‏
670 ‎‡a Author's Disease-specific quality of life in young patients with tourette syndrome‏
670 ‎‡a Author's Disentangling the effects of Tourette syndrome and attention deficit hyperactivity disorder on cognitive and behavioral phenotypes‏
670 ‎‡a Author's DNA repair investigations in nine Italian patients affected by trichothiodystrophy.‏
670 ‎‡a Author's Erratum to: Long-term outcome of epilepsy in patients with Prader–Willi syndrome‏
670 ‎‡a Author's European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment‏
670 ‎‡a Author's Evaluation of the LIM homeobox genes LHX6 and LHX8 as candidates for Tourette syndrome‏
670 ‎‡a Author's Familial broad terminal phalanges with one individual showing additional anomalies‏
670 ‎‡a Author's Febrile and afebrile convulsions: a clinical follow-up‏
670 ‎‡a Author's Fragile X syndrome associated with tic disorders.‏
670 ‎‡a Author's Genetic association signal near NTN4 in Tourette syndrome‏
670 ‎‡a Author's Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents‏
670 ‎‡a Author's Hemihydranencephaly: living with half brain dysfunction‏
670 ‎‡a Author's Identification of C7orf11 (TTDN1) gene mutations and genetic heterogeneity in nonphotosensitive trichothiodystrophy‏
670 ‎‡a Author's Incidence of Autism Spectrum Disorder in Youths Affected by Gilles de la Tourette Syndrome Based on Data from a Large Single Italian Clinical Cohort‏
670 ‎‡a Author's Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study‏
670 ‎‡a Author's Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies‏
670 ‎‡a Author's Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome.‏
670 ‎‡a Author's Lack of Evidence for Association Between D2S124 and D2S111 Polymorphisms of the SCN2A Gene and Idiopathic Generalized Epilepsy With Generalized Tonic—Clonic Seizures‏
670 ‎‡a Author's Lateral dermoid cyst of the tongue: case report‏
670 ‎‡a Author's Long term clinical course of Tourette syndrome‏
670 ‎‡a Author's Long-term neurological outcome of a sextuplet pregnancy.‏
670 ‎‡a Author's Long-term outcome of epilepsy in patients with Prader-Willi syndrome.‏
670 ‎‡a Author's Mandatory electrocardiographic monitoring in young patients treated with psychoactive drugs‏
670 ‎‡a Author's Metabolic Effects of Aripiprazole and Pimozide in Children With Tourette Syndrome‏
670 ‎‡a Author's Neuropsychological aspects of Tourette syndrome: a review‏
670 ‎‡a Author's New multiple congenital anomalies: mental retardation syndrome (MCA/MR) with facio-cutaneous-skeletal involvement.‏
670 ‎‡a Author's Oculogyric crisis: a rare extrapyramidal side effect in the treatment of Tourette syndrome‏
670 ‎‡a Author's Olivopontocerebellar atrophy leading to recognition of carbohydrate-deficient glycoprotein syndrome type I.‏
670 ‎‡a Author's Parent and self-report health-related quality of life measures in young patients with Tourette syndrome‏
670 ‎‡a Author's Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients: A 2-Year Naturalistic Comparison.‏
670 ‎‡a Author's Point mutations throughout the GLI3 gene cause Greig cephalopolysyndactyly syndrome.‏
670 ‎‡a Author's Primary osteoma cutis — multiple café-au-lait spots and woolly hair anomaly‏
670 ‎‡a Author's Proximal femoral focal deficiency‏
670 ‎‡a Author's Proximal femoral focal deficiency (PFFD) and fibular A/hypoplasia (FA/H): a model of a developmental field defect.‏
670 ‎‡a Author's Quality of life in young people with Tourette syndrome: a controlled study‏
670 ‎‡a Author's Quality of life in young people with treatment-responsive epilepsy: A controlled study‏
670 ‎‡a Author's Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette Syndrome‏
670 ‎‡a Author's Replication of association between a SLITRK1 haplotype and Tourette Syndrome in a large sample of families.‏
670 ‎‡a Author's Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switch.‏
670 ‎‡a Author's Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families‏
670 ‎‡a Author's TBR1is the candidate gene for intellectual disability in patients with a 2q24.2 interstitial deletion‏
670 ‎‡a Author's The Gilles de la Tourette Syndrome-Quality of Life Scale for children and adolescents‏
670 ‎‡a Author's The Gilles de la Tourette Syndrome-Quality of Life Scale for children and adolescents (C&A-GTS-QOL): development and validation of the Italian version.‏
670 ‎‡a Author's The Kabuki‏
670 ‎‡a Author's The Kabuki (Niikawa-Kuroki) syndrome: further delineation of the phenotype in 29 non-Japanese patients‏
670 ‎‡a Author's The perception of time in childhood migraine‏
670 ‎‡a Author's The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort‏
670 ‎‡a Author's The successful use of ondansetron in a boy with both leukemia and Tourette syndrome‏
670 ‎‡a Author's Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings‏
670 ‎‡a Author's Three Cases of Palatal Tics and Gilles De La Tourette Syndrome‏
670 ‎‡a Author's Timing recalibration in childhood Tourette syndrome associated with persistent pimozide treatment‏
670 ‎‡a Author's Tourette syndrome and comorbid ADHD: causes and consequences.‏
670 ‎‡a Author's Tourette Syndrome and comorbid ADHD: current pharmacological treatment options‏
670 ‎‡a Author's Tourette syndrome and comorbid conditions: a spectrum of different severities and complexities‏
670 ‎‡a Author's Tourette syndrome: current data, comorbidities, and therapeutic approach in children‏
909 ‎‡a (scopus) 7101923208‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000239971328‏ ‎‡9 1‏
919 ‎‡a qualityoflifeinyoungpeoplewithtourettesyndromeacontrolledstudy‏ ‎‡A Quality of life in young people with Tourette syndrome: a controlled study‏ ‎‡9 1‏
919 ‎‡a proximalfemoralfocaldeficiencypffdandfibularahypoplasiafahamodelofadevelopmentalfielddefect‏ ‎‡A Proximal femoral focal deficiency (PFFD) and fibular A/hypoplasia (FA/H): a model of a developmental field defect.‏ ‎‡9 1‏
919 ‎‡a proximalfemoralfocaldeficiency‏ ‎‡A Proximal femoral focal deficiency‏ ‎‡9 1‏
919 ‎‡a primaryosteomacutismultiplecafeaulaitspotsandwoollyhairanomaly‏ ‎‡A Primary osteoma cutis — multiple café-au-lait spots and woolly hair anomaly‏ ‎‡9 1‏
919 ‎‡a pointmutationsthroughoutthegli3genecausegreigcephalopolysyndactylysyndrome‏ ‎‡A Point mutations throughout the GLI3 gene cause Greig cephalopolysyndactyly syndrome.‏ ‎‡9 1‏
919 ‎‡a persistenceintherapywithrisperidoneandaripiprazoleinpediatricoutpatientsa2yearnaturalisticcomparison‏ ‎‡A Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients: A 2-Year Naturalistic Comparison.‏ ‎‡9 1‏
919 ‎‡a parentandselfreporthealthrelatedqualityoflifemeasuresinyoungpatientswithtourettesyndrome‏ ‎‡A Parent and self-report health-related quality of life measures in young patients with Tourette syndrome‏ ‎‡9 1‏
919 ‎‡a olivopontocerebellaratrophyleadingtorecognitionofcarbohydratedeficientglycoproteinsyndrometype1‏ ‎‡A Olivopontocerebellar atrophy leading to recognition of carbohydrate-deficient glycoprotein syndrome type I.‏ ‎‡9 1‏
919 ‎‡a oculogyriccrisisarareextrapyramidalsideeffectinthetreatmentoftourettesyndrome‏ ‎‡A Oculogyric crisis: a rare extrapyramidal side effect in the treatment of Tourette syndrome‏ ‎‡9 1‏
919 ‎‡a newmultiplecongenitalanomaliesmentalretardationsyndromemcamrwithfaciocutaneousskeletalinvolvement‏ ‎‡A New multiple congenital anomalies: mental retardation syndrome (MCA/MR) with facio-cutaneous-skeletal involvement.‏ ‎‡9 1‏
919 ‎‡a neuropsychologicalaspectsoftourettesyndromeareview‏ ‎‡A Neuropsychological aspects of Tourette syndrome: a review‏ ‎‡9 1‏
919 ‎‡a metaboliceffectsofaripiprazoleandpimozideinchildrenwithtourettesyndrome‏ ‎‡A Metabolic Effects of Aripiprazole and Pimozide in Children With Tourette Syndrome‏ ‎‡9 1‏
919 ‎‡a mandatoryelectrocardiographicmonitoringinyoungpatientstreatedwithpsychoactivedrugs‏ ‎‡A Mandatory electrocardiographic monitoring in young patients treated with psychoactive drugs‏ ‎‡9 1‏
919 ‎‡a longtermoutcomeofepilepsyinpatientswithpraderwillisyndrome‏ ‎‡A Long-term outcome of epilepsy in patients with Prader-Willi syndrome.‏ ‎‡9 1‏
919 ‎‡a longtermneurologicaloutcomeofasextupletpregnancy‏ ‎‡A Long-term neurological outcome of a sextuplet pregnancy.‏ ‎‡9 1‏
919 ‎‡a longtermclinicalcourseoftourettesyndrome‏ ‎‡A Long term clinical course of Tourette syndrome‏ ‎‡9 1‏
919 ‎‡a lateraldermoidcystofthetonguecasereport‏ ‎‡A Lateral dermoid cyst of the tongue: case report‏ ‎‡9 1‏
919 ‎‡a lackofevidenceforassociationbetweend2s124andd2s111polymorphismsofthescn2ageneandidiopathicgeneralizedepilepsywithgeneralizedtonicclonicseizures‏ ‎‡A Lack of Evidence for Association Between D2S124 and D2S111 Polymorphisms of the SCN2A Gene and Idiopathic Generalized Epilepsy With Generalized Tonic—Clonic Seizures‏ ‎‡9 1‏
919 ‎‡a intragenicdeletionsaffecting2alternativetranscriptsoftheimmp2lgeneinpatientswithtourettesyndrome‏ ‎‡A Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome.‏ ‎‡9 1‏
919 ‎‡a interrogatingthegeneticdeterminantsoftourettessyndromeandotherticdisordersthroughgenomewideassociationstudies‏ ‎‡A Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies‏ ‎‡9 1‏
919 ‎‡a increasedantistreptococcalantibodytitersandantibasalgangliaantibodiesinpatientswithtourettesyndromecontrolledcrosssectionalstudy‏ ‎‡A Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study‏ ‎‡9 1‏
919 ‎‡a incidenceofautismspectrumdisorderinyouthsaffectedbygillesdelatourettesyndromebasedondatafromalargesingleitalianclinicalcohort‏ ‎‡A Incidence of Autism Spectrum Disorder in Youths Affected by Gilles de la Tourette Syndrome Based on Data from a Large Single Italian Clinical Cohort‏ ‎‡9 1‏
919 ‎‡a identificationofc7orf11ttdn1genemutationsandgeneticheterogeneityinnonphotosensitivetrichothiodystrophy‏ ‎‡A Identification of C7orf11 (TTDN1) gene mutations and genetic heterogeneity in nonphotosensitive trichothiodystrophy‏ ‎‡9 1‏
919 ‎‡a hemihydranencephalylivingwithhalfbraindysfunction‏ ‎‡A Hemihydranencephaly: living with half brain dysfunction‏ ‎‡9 1‏
919 ‎‡a guanfacineforthetreatmentofattentiondeficithyperactivitydisorderinchildrenandadolescents‏ ‎‡A Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents‏ ‎‡9 1‏
919 ‎‡a geneticassociationsignalnearntn4intourettesyndrome‏ ‎‡A Genetic association signal near NTN4 in Tourette syndrome‏ ‎‡9 1‏
919 ‎‡a fragile10syndromeassociatedwithticdisorders‏ ‎‡A Fragile X syndrome associated with tic disorders.‏ ‎‡9 1‏
919 ‎‡a febrileandafebrileconvulsionsaclinicalfollowup‏ ‎‡A Febrile and afebrile convulsions: a clinical follow-up‏ ‎‡9 1‏
919 ‎‡a familialbroadtermin Alpha langeswith1individualshowingadditionalanomalies‏ ‎‡A Familial broad terminal phalanges with one individual showing additional anomalies‏ ‎‡9 1‏
919 ‎‡a evaluationofthelimhomeoboxgeneslhx6andlhx8ascandidatesfortourettesyndrome‏ ‎‡A Evaluation of the LIM homeobox genes LHX6 and LHX8 as candidates for Tourette syndrome‏ ‎‡9 1‏
919 ‎‡a europeanclinicalguidelinesfortourettesyndromeandotherticdisorderspart1assessment‏ ‎‡A European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment‏ ‎‡9 1‏
919 ‎‡a erratumtolongtermoutcomeofepilepsyinpatientswithpraderwillisyndrome‏ ‎‡A Erratum to: Long-term outcome of epilepsy in patients with Prader–Willi syndrome‏ ‎‡9 1‏
919 ‎‡a dnarepairinvestigationsin9italianpatientsaffectedbytrichothiodystrophy‏ ‎‡A DNA repair investigations in nine Italian patients affected by trichothiodystrophy.‏ ‎‡9 1‏
919 ‎‡a disentanglingtheeffectsoftourettesyndromeandattentiondeficithyperactivitydisorderoncognitiveandbehavioralphenotypes‏ ‎‡A Disentangling the effects of Tourette syndrome and attention deficit hyperactivity disorder on cognitive and behavioral phenotypes‏ ‎‡9 1‏
919 ‎‡a diseasespecificqualityoflifeinyoungpatientswithtourettesyndrome‏ ‎‡A Disease-specific quality of life in young patients with tourette syndrome‏ ‎‡9 1‏
919 ‎‡a csfnglycanprofilerevealssialylationdeficiencyinapatientwithgm2gangliosidosispresentingaschildhooddisintegrativedisorder‏ ‎‡A CSF N-glycan profile reveals sialylation deficiency in a patient with GM2 gangliosidosis presenting as childhood disintegrative disorder‏ ‎‡9 1‏
919 ‎‡a craniofacialanomaliesseverecerebellarhypoplasiapsychomotorandgrowthdelayinachildwithcongenitalhypothyroidism‏ ‎‡A Craniofacial anomalies, severe cerebellar hypoplasia, psychomotor and growth delay in a child with congenital hypothyroidism‏ ‎‡9 1‏
919 ‎‡a convulsivedisorderandgeneticpolymorphismassociationofidiopathicgeneralizedepilepsywithhaptoglobinpolymorphism‏ ‎‡A Convulsive disorder and genetic polymorphism. Association of idiopathic generalized epilepsy with haptoglobin polymorphism‏ ‎‡9 1‏
919 ‎‡a clinic Alpha rmacologyofcomorbidattentiondeficithyperactivitydisorderintourettesyndrome‏ ‎‡A Clinical pharmacology of comorbid attention deficit hyperactivity disorder in Tourette syndrome‏ ‎‡9 1‏
919 ‎‡a clinicalmanifestationsandevaluationofisolatedlissencephaly‏ ‎‡A Clinical manifestations and evaluation of isolated lissencephaly‏ ‎‡9 1‏
919 ‎‡a clinicalcorrelatesofqualityoflifeintourettesyndrome‏ ‎‡A Clinical correlates of quality of life in Tourette syndrome‏ ‎‡9 1‏
919 ‎‡a circulatingmirnasprofilesintourettesyndromemoleculardataandclinicalimplications‏ ‎‡A Circulating miRNAs profiles in Tourette syndrome: molecular data and clinical implications.‏ ‎‡9 1‏
919 ‎‡a cardiovascularsafetyofaripiprazoleandpimozideinyoungpatientswithtourettesyndrome‏ ‎‡A Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome‏ ‎‡9 1‏
919 ‎‡a blinkreflexabnormalitiesinchildrenwithtourettesyndrome‏ ‎‡A Blink reflex abnormalities in children with Tourette syndrome‏ ‎‡9 1‏
919 ‎‡a autosomalrecessivemicrocephalyin2siblings1withnormaliqandbothwithprotrudingmandiblesmallearsandcurvednose‏ ‎‡A Autosomal-recessive microcephaly in two siblings, one with normal IQ and both with protruding mandible, small ears, and curved nose.‏ ‎‡9 1‏
919 ‎‡a autosomaldominantandsporadicradioulnarsynostosis‏ ‎‡A Autosomal dominant and sporadic radio-ulnar synostosis.‏ ‎‡9 1‏
919 ‎‡a autoimmuneneuropsychiatricdisordersassociatedwithstreptococcalinfectionsydenhamchoreapandasandpandasvariants‏ ‎‡A Autoimmune neuropsychiatric disorders associated with streptococcal infection: Sydenham chorea, PANDAS, and PANDAS variants‏ ‎‡9 1‏
919 ‎‡a associationoftrp53polymorphicvariantsatcodon72withnonsyndromicmentalretardation‏ ‎‡A Association of Trp53 polymorphic variants at codon 72 with nonsyndromic mental retardation.‏ ‎‡9 1‏
919 ‎‡a associationofadenosinedeaminasepolymorphismwithmildmentalretardation‏ ‎‡A Association of adenosine deaminase polymorphism with mild mental retardation.‏ ‎‡9 1‏
919 ‎‡a associationbetweend18s474locusonchromosome18q12andidiopathicgeneralizedepilepsy‏ ‎‡A Association between D18S474 locus on chromosome 18q12 and idiopathic generalized epilepsy‏ ‎‡9 1‏
919 ‎‡a antibrainantibodiesinpandasversusuncomplicatedstreptococcalinfection‏ ‎‡A Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection‏ ‎‡9 1‏
919 ‎‡a aggressivebehaviorinpatientswithsotossyndrome‏ ‎‡A Aggressive behavior in patients with Sotos syndrome.‏ ‎‡9 1‏
919 ‎‡a adhdandepilepsyinchildrenwithtourettesyndromeatriplecomorbidity‏ ‎‡A ADHD and Epilepsy in children with Tourette Syndrome: a triple comorbidity?‏ ‎‡9 1‏
919 ‎‡a tourettesyndromeandcomorbidadhdcausesandconsequences‏ ‎‡A Tourette syndrome and comorbid ADHD: causes and consequences.‏ ‎‡9 1‏
919 ‎‡a tourettesyndromeandcomorbidadhdcurrentpharmacologicaltreatmentoptions‏ ‎‡A Tourette Syndrome and comorbid ADHD: current pharmacological treatment options‏ ‎‡9 1‏
919 ‎‡a tourettesyndromeandcomorbidconditionsaspectrumofdifferentseveritiesandcomplexities‏ ‎‡A Tourette syndrome and comorbid conditions: a spectrum of different severities and complexities‏ ‎‡9 1‏
919 ‎‡a tourettesyndromecurrentdatacomorbiditiesandtherapeuticapproachinchildren‏ ‎‡A Tourette syndrome: current data, comorbidities, and therapeutic approach in children‏ ‎‡9 1‏
919 ‎‡a timingrecalibrationinchildhoodtourettesyndromeassociatedwithpersistentpimozidetreatment‏ ‎‡A Timing recalibration in childhood Tourette syndrome associated with persistent pimozide treatment‏ ‎‡9 1‏
919 ‎‡a 3casesofpalatalticsandgillesdelatourettesyndrome‏ ‎‡A Three Cases of Palatal Tics and Gilles De La Tourette Syndrome‏ ‎‡9 1‏
919 ‎‡a therapeuticdrugmonitoringof2generationantipsychoticsinpediatricpatientsanobservationalstudyinreallifesettings‏ ‎‡A Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings‏ ‎‡9 1‏
919 ‎‡a successfuluseofondansetroninaboywithbothleukemiaandtourettesyndrome‏ ‎‡A The successful use of ondansetron in a boy with both leukemia and Tourette syndrome‏ ‎‡9 1‏
919 ‎‡a relationshipbetweengroupastreptococcalinfectionsandtourettesyndromeastudyonalargeservicebasedcohort‏ ‎‡A The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort‏ ‎‡9 1‏
919 ‎‡a perceptionoftimeinchildhoodmigraine‏ ‎‡A The perception of time in childhood migraine‏ ‎‡9 1‏
919 ‎‡a kabukiniikawakurokisyndromefurtherdelineationofthephenotypein29nonjapanesepatients‏ ‎‡A The Kabuki (Niikawa-Kuroki) syndrome: further delineation of the phenotype in 29 non-Japanese patients‏ ‎‡9 1‏
919 ‎‡a kabuki‏ ‎‡A The Kabuki‏ ‎‡9 1‏
919 ‎‡a gillesdelatourettesyndromequalityoflifescaleforchildrenandadolescentsc&agtsqoldevelopmentandvalidationoftheitalianversion‏ ‎‡A The Gilles de la Tourette Syndrome-Quality of Life Scale for children and adolescents (C&A-GTS-QOL): development and validation of the Italian version.‏ ‎‡9 1‏
919 ‎‡a gillesdelatourettesyndromequalityoflifescaleforchildrenandadolescents‏ ‎‡A The Gilles de la Tourette Syndrome-Quality of Life Scale for children and adolescents‏ ‎‡9 1‏
919 ‎‡a tbr1isthecandidategeneforintellectualdisabilityinpatientswitha2q242interstitialdeletion‏ ‎‡A TBR1is the candidate gene for intellectual disability in patients with a 2q24.2 interstitial deletion‏ ‎‡9 1‏
919 ‎‡a supportofthehistaminergichypothesisintourettesyndromeassociationofthehistaminedecarboxylasegeneinalargesampleoffamilies‏ ‎‡A Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families‏ ‎‡9 1‏
919 ‎‡a 2generationantipsychoticsinreallifepaediatricpatientsadversedrugreactionsandclinicaloutcomesofdrugswitch‏ ‎‡A Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switch.‏ ‎‡9 1‏
919 ‎‡a replicationofassociationbetweenaslitrk1haplotypeandtourettesyndromeinalargesampleoffamilies‏ ‎‡A Replication of association between a SLITRK1 haplotype and Tourette Syndrome in a large sample of families.‏ ‎‡9 1‏
919 ‎‡a rarecopynumbervariantsinnrxn1andcntn6increaseriskfortourettesyndrome‏ ‎‡A Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette Syndrome‏ ‎‡9 1‏
919 ‎‡a qualityoflifeinyoungpeoplewithtreatmentresponsiveepilepsyacontrolledstudy‏ ‎‡A Quality of life in young people with treatment-responsive epilepsy: A controlled study‏ ‎‡9 1‏
946 ‎‡a a‏ ‎‡9 1‏
996 ‎‡2 NUKAT|n 2020210043‏
996 ‎‡2 BAV|495_315813‏
997 ‎‡a 1900 0 flourished 0000 0‏ ‎‡9 1‏